If you have been reading about CJC-1295 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-01-18. Numbers and descriptions here follow the published literature rather than marketing material.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
| Property | Value | Notes |
|---|---|---|
| Primary target | GHRH receptor | G-protein-coupled receptor on pituitary somatotrophs |
| Half-life, long-acting form | Several days | Extended by covalent albumin binding |
| Half-life, short form | About 30 minutes | Cleared rapidly by peptidases and kidneys |
| Route in studies | Subcutaneous injection | Used in the published human trials |
| Main measured effect | Rise in GH and IGF-1 | Surrogate markers rather than clinical endpoints |
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.
For services to the community in Crowborough, East Sussex. Dorothy Christine Flynn. For services to Young People in Winchester, Hampshire. Thomas William Foley, Warder Supervisor, National Gallery. Patricia Folland. For services to Young People in South Shields, Tyne and Wear. Pauline Anne Force, School Secretary, Oakfield County Primary Junior School, Dartford, Kent. For services to Education. James Paton Hunter Ford, Team Leader/Instructor, Steelwork, Yarrow Shipbuilders Ltd. For services to the Shipbuilding Industry. Robert Peter Ford, Sorter, Parcelforce, East Midlands. For services to the Post Office and to Industrial Relations. Audley Moraise Forrester, Interchange Manager, South Yorkshire Passenger Transport Executive. For services to Public Transport. John Robert Fortnam, Group Purchase Manager, Aerospace Group, Rolls-Royce plc. For services to the Aerospace Industry. Alfred Foster, Founder, African Leprosy Aid. For charitable services. John Christopher Foxley, Water Supply Manager, Southern Water. For services to the Water Industry. Annis Grace Campbell Frackelton. For services to Family Care in Edinburgh. Lesley Margaret Freeman, Range D, Her Majesty's Treasury. Michael William Thomas Freeman, Inspector, Lincolnshire Constabulary. For services to the community. Denzil Kingson Freeth. For services to the Church of England in London. Patricia Froomberg. For services to disabled people. Norah Fryer. For services to Elderly People in Church Lawton, Cheshire. Michael Fuller, Laboratory Services Manager, Laboratory of Molecular Biology. For services to Biology.
The integration of different regulatory signals by gonadotropes results in the coordinated control of production and secretion of gonadotropins to respond and control sexual maturation and reproductive functions.
Coconut milk powder is a fine, white powder used in Southeast Asian and other cuisines. Coconut milk powder is manufactured through the spray drying process of raw unsweetened coconut cream and is reconstituted with water for use in recipes that call for coconut milk. Many commercially available coconut milk powders list milk or casein among their ingredients. Some coconut milk powder formulations may have added ingredients such as maltodextrin, sodium caseinate, or trisodium phosphate.
But that is not the only reason why the silver nanoparticles are so appealing, they do not require any external force (no electricity of hydrolics) for the reaction to occur. Conversely, post-consumer silver nanoparticles in waste water may adversely impact biological agents used in waste water treatment.
Sources: en.wikipedia.org
=== Psychiatry === Acetylcysteine has been studied for major psychiatric disorders, including bipolar disorder, major depressive disorder, and schizophrenia. Preliminary research indicates N-acetylcysteine may be useful in treating obsessive-compulsive disorder, specific drug addictions (cocaine), drug-induced neuropathy, trichotillomania, excoriation disorder, and a certain form of epilepsy (progressive myoclonic). Other research has tested N-acetylcysteine in anxiety disorder, attention deficit hyperactivity disorder and mild traumatic brain injury, although its efficacy for these conditions remains unestablished.
==== El Salvador ==== According to a visual investigation report by The New York Times, satellite imagery and other data revealed the US began operating aircraft out of El Salvador in mid-October; the three aircraft identified included the Air Force's AC-130J Ghostrider, which is "designed to destroy targets on the ground or at sea using missiles or barrages from its cannons and machine guns" along with a P8–A Poseidon operated by the Navy, and a C-40 Clipper, about which little is known. The report stated that "the deployment ... is likely to be the first time a foreign country has hosted US planes that may be involved in military strikes in the region". According to The War Zone, the P-8 is the "most advanced maritime patrol aircraft in the world and is specifically capable of collecting multiple types of intelligence to find small targets in vast bodies of water".
==== Reduction ==== Reduction of the carbonyl groups of chiral 2,5-diketopiperazine with lithium aluminium hydride (LiAlH4) cleanly gives the corresponding chiral piperazines. For example, cyclo(L-Phe-L-Phe) 1 gives the chiral piperazine (2S,5S)-dibenzylpiperazine 2.
Desmethylprodine or 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP, Ro 2-0718) is an opioid analgesic drug developed in the 1940s by researchers at Hoffmann-La Roche. Desmethylprodine has been labeled by the DEA as a Schedule I drug in the United States. It is an analog of pethidine (meperidine), a Schedule II drug. Chemically, it is a reversed ester of pethidine which has about 70% of the potency of morphine. Unlike its derivative prodine, it does not exhibit optical isomerism. It was reported to have 30 times the activity of pethidine and a greater analgesic effect than morphine in rats, and it was demonstrated to cause central nervous system stimulation in mice.
Atomoxetine contains an aryloxy propylamine moiety that has been linked to monoamine reuptake inhibitory activity. It's selectivity to the norepinephrine transporter (NET) is due to its methyl substituent in the 2' position on the phenyl ring. Research has shown that a methyl group in position 2' provides more affinity towards NET than a methoxy group in the same position. The amine group of atomoxetine binds to the amino acids of NET with a salt bridge and hydrogen bonds while the phenyl and methylphenyl groups have hydrophobic interactions. Reboxetine has two chiral centers and the active ingredient is a mixture of the (R,R)-(-)- and (S,S)-(+) enantiomers. Reboxetine, like atomoxetine, contains an aryloxy propylamine moiety and has an ethoxy group in position 2' on the phenyl ring. But the main difference from atomoxetine is the morpholine group instead of a secondary amine. The morpholine group of reboxetine forms a salt bridge and hydrogen bonds with the amino acids of NET. While the phenyl and ethyloxyphenyl groups form hydrophobic interactions. The aryloxy propylamine moiety is also found in many other monoamine reuptake inhibitors, but the placement of substituents on the phenyl ring determine the selectivity. Compounds with substituents in position 2' have selectivity for NET. Compounds with substituents in position 4' are selective serotonin reuptake inhibitors e.g. fluoxetine and paroxetine. Then there is duloxetine which has a phenyl group attached at positions 2' and 3' and has a similar affinity for both transporters.
Sources: en.wikipedia.org
Somalia has reserves of several natural resources, including uranium, iron ore, tin, gypsum, bauxite, copper, salt and natural gas. The CIA reported that there are 5.663 billion cubic metres of proven natural gas reserves. The presence or extent of proven oil reserves in Somalia is uncertain. The CIA asserts that as of 2011 there are no proven reserves of oil in the country, while UNCTAD suggests that most proven oil reserves in Somalia lie off its northwestern coast, in the Somaliland region. An oil group listed in Sydney, Range Resources, estimates that the Puntland region in the northeast has the potential to produce 5 billion barrels (790×10^6 m3) to 10 billion barrels (1.6×10^9 m3) of oil, compared to the 6.7 billion barrels of proven oil reserves in Sudan. As a result of these developments, the Somalia Petroleum Corporation was established by the federal government. In the late 1960s, UN geologists discovered major uranium deposits and other rare mineral reserves in Somalia. The find was the largest of its kind, with industry experts estimating that the amount of the deposits could amount to over 25% of the world's then known uranium reserves of 800,000 tons. In 1984, the IUREP Orientation Phase Mission to Somalia reported that the country had 5,000 tons of uranium reasonably assured resources (RAR), 11,000 tons of uranium estimated additional resources (EAR) in calcrete deposits, as well as 0–150,000 tons of uranium speculative resources (SR) in sandstone and calcrete deposits.
== Chemistry == Epimedium wushanense contains a number of flavonoids. 37 compounds were characterized from the underground and aerial parts of the plant. Among them, 28 compounds were prenylflavonoids. The predominant flavonoid, epimedin C, ranged from 1.4 to 5.1% in aerial parts and 1.0 to 2.8% in underground parts.
==== Metabolism and elimination ==== 5α-Reductase is a major enzyme involved in the metabolism of progesterone and is known to be expressed in skin in high amounts. For this reason, it has been suggested that rapid metabolism of progesterone by 5α-reductase could account for the low levels of circulating progesterone produced by transdermal application. Studies of progesterone have reported that when progesterone is administered transdermally, 80% is metabolized in the skin and only 20% is likely to pass the skin barrier. Along these lines, a study of radiolabeled progesterone found that 5β-reduced pregnanediol excretion was 8-fold higher than 5α-reduced allopregnanediol excretion with intravenous progesterone yet allopregnanediol excretion was slightly higher than pregnanediol excretion with transdermal progesterone. The metabolites of progesterone in the skin seem to have no hormonal activity. In addition to 5α-reductase, other enzymes, such as 20α-hydroxysteroid dehydrogenase, metabolize progesterone in the skin. Progesterone and/or its metabolites such as 5α-dihydroprogesterone act as 5α-reductase inhibitors and inhibitors of 3α- and 3β-hydroxysteroid dehydrogenases in the skin. On the other hand, other research has cast doubt on the notion that progesterone is robustly metabolized in the skin. One study reported that transdermal progesterone in an alcohol-based gel produced high levels of circulating progesterone. This suggests that formulation rather than metabolism might be a critical limiting factor for the bioavailability of transdermal progesterone.
=== 12 September === Ten people were killed in an RSF raid on the Al-Nasr neighborhood of El Fasher. The United States imposed sanctions on finance minister and Justice and Equality Movement leader Gibril Ibrahim and the Al-Bara' ibn Malik Battalion for their role in the civil war and connections with Iran.
Sources: en.wikipedia.org
It binds the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Receptor activation raises cyclic AMP and promotes release of stored growth hormone granules. Because the peptide persists longer than natural releasing hormone, stimulation is prolonged rather than brief.
The drug affinity complex links the peptide to serum albumin through a covalent bond. The conjugate is too large to be filtered quickly by the kidneys and is shielded from enzymatic breakdown. This extends the apparent half-life from roughly minutes to several days.
Long-term safety and any clinical benefit are unestablished. Published human data cover small groups over limited periods and focus on hormone levels rather than health outcomes. Whether prolonged elevation of growth hormone and insulin-like growth factor 1 is beneficial or harmful is an open question.
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.